Biogen Idec Inc (NASDAQ:BIIB)

During the Trading Day
336.39 +0.94 / +0.28%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
336.39 0.00 / 0.00%
 
Volume: 6.2K

Stock Price Forecast

The 18 analysts offering 12-month price forecasts for Biogen Idec Inc have a median target of 388.00, with a high estimate of 474.00 and a low estimate of 294.00. The median estimate represents a +15.34% increase from the last price of 336.39.

Analyst Recommendations

The current consensus among 25 polled investment analysts is to Buy stock in Biogen Idec Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$3.39
Sales
$2.4B
Reporting Date
Jul 23

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 37.15%
 
 
 
 
 
 
Growthannually 42.47%
 
 
 
 
 
 

Sales

Growthquarterly 11.72%
 
 
 
 
 
 
Growthannually 37.50%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.